Advertisement

Doklady Biochemistry and Biophysics

, Volume 413, Issue 1, pp 65–67 | Cite as

CombiHIV vac vaccine which contains polypepitope B-and T-cell immunogens of HIV-1

  • L. I. Karpenko
  • S. I. Bazhan
  • A. M. Eroshkin
  • L. R. Lebedev
  • R. V. Uzhachenko
  • N. A. Nekrasova
  • O. A. Plyasunova
  • P. A. Belavin
  • S. V. Seregin
  • N. K. Danilyuk
  • E. D. Danilenko
  • B. N. Zaitsev
  • V. I. Masicheva
  • A. A. Ilyichev
  • L. S. Sandakhchiev
Biochemistry, Biophysics, and Molecular Biology

Keywords

DOKLADY Biochemistry Neutralization Index Serum Dilu ELISpot Test Vaccine Injection Site 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Girard, M.C., Osmanov, S.K., and Kieny, M.P., Vaccine, 2006, vol. 24, pp. 4062–4081.PubMedCrossRefGoogle Scholar
  2. 2.
    Hanke, T., Schneider, J., Gilbert, S.C., et al., Vaccine, 1998, vol. 16, pp. 426–435.PubMedCrossRefGoogle Scholar
  3. 3.
    Goonetilleke, N., Moore, S., Dally, L., et al., J. Virol., 2006, vol. 80, no. 10, pp. 4717–4728.PubMedCrossRefGoogle Scholar
  4. 4.
    Firat, H., Tourdot, S., Ureta-Vidal, A., et al., Europ. J. Immunol, 2001, vol. 10, no. 10, pp. 3064–3074.CrossRefGoogle Scholar
  5. 5.
    Lorin, C., Delebecque, F., Labrousse, V., et al., Vaccine, 2005, vol. 23, no. 36, pp. 4463–4472.PubMedCrossRefGoogle Scholar
  6. 6.
    Eroshkin, A.M., Karginova, E.A., Gileva, I.P., et al., Protein Eng., 1995, vol. 8, pp. 167–173.PubMedCrossRefGoogle Scholar
  7. 7.
    Loktev, V.B., Ilyichev, A.A., Eroshkin, A.M., et al., J. Biotechnol., 1996, vol. 44, nos. 1–3, pp. 129–137.PubMedCrossRefGoogle Scholar
  8. 8.
    Bazhan, S.I., Belavin, P.A., Seregin, S.V., et al., Vaccine, 2004, vol. 22, nos. 13/14, pp. 1672–1682.PubMedCrossRefGoogle Scholar
  9. 9.
    Karpenko, L.I., Nekrasova, N.A., Ilyichev, A.A., et al., Vaccine, 2004, vol. 22, nos. 13/14, pp. 1692–1699.PubMedCrossRefGoogle Scholar
  10. 10.
    Il’ichev, A.A., Karpenko, L.I., Nekrasova, N.A., et al., Vestn. Ross. Akad. Med. Nauk, 2005, no. 1, pp. 41–44.Google Scholar
  11. 11.
    Bazhan, S.I., Belavin, P.A., Seregin, S.V., et al., Dokl. Biochem. Biophys., 2004, vol. 395, no. 6, pp. 108–110 [Dokl. Akad. Nauk, 2004, vol. 395, no. 6, pp. 825–827].PubMedCrossRefGoogle Scholar
  12. 12.
    Karpenko, L.I., Bazhan, S.I., Ignat’ev, G.M., et al., Vestn. Ross. Akad. Med. Nauk, 2003, no. 1, pp. 24–30.Google Scholar
  13. 13.
    Karamov, E.V., Pavlova, T.V., Kornilaeva, G.V., et al., Allerg. Astma Klin. Immunol., 2003, no. 9, pp. 151–158.Google Scholar

Copyright information

© Pleiades Publishing, Ltd. 2007

Authors and Affiliations

  • L. I. Karpenko
    • 1
  • S. I. Bazhan
    • 1
  • A. M. Eroshkin
    • 1
  • L. R. Lebedev
    • 1
  • R. V. Uzhachenko
    • 1
  • N. A. Nekrasova
    • 1
  • O. A. Plyasunova
    • 1
  • P. A. Belavin
    • 1
  • S. V. Seregin
    • 1
  • N. K. Danilyuk
    • 1
  • E. D. Danilenko
    • 1
  • B. N. Zaitsev
    • 1
  • V. I. Masicheva
    • 1
  • A. A. Ilyichev
    • 1
  • L. S. Sandakhchiev
    • 1
  1. 1.Vector State Scientific Center of Virology and BiotechnologyKol’tsovo, Novosibirsk oblastRussia

Personalised recommendations